MedTrace Logo

To Evaluate Effectiveness and Safety of Containing Raltegravir in Naive HIV NON B or B Infected Patients

NCT01162538 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2010-07-14

No results posted yet for this study

Summary

Pilot open label multicentric study

Conditions

  • Evaluated
  • Non B Subtype
  • Naive Patients

Sponsors & Collaborators

  • Centre Hospitalier Intercommunal Robert Ballanger

    lead OTHER

Principal Investigators

  • Delassus Jean-Luc, MD · Réseau Aulnay 93

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-03-31
Completion
2012-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01162538 on ClinicalTrials.gov